Company intelligence / Profile preview

Biomedica

Vienna, Vienna, Austria

Ownership: Private
Employees: ~180
Development stage: Other

Overview

Biomedica has fully validated and CE-certified immunoassay kits (primarily ELISA) in commercial use globally, with leadership in biomarker assessment for nephrology, cardiology, oncology, and musculoskeletal condition research; offers custom assay development and testing services

Therapeutic areas: ImmunologyEndocrinologyNephrologyMetabolic DisordersInfectious DiseasesCardiovascularOtherOncologyNeurology
Modalities: ImmunoassayELISA assayDiagnostic kitCustom testing services
Industry: Protein Biomarker Diagnostics

Partnerships

The Antibody Lab GmbHTAmiRNA (microRNA diagnostics)Multiple pharma and biotech companies via distribution

Beyond the preview

Go deeper on Biomedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedica.

Explore the full profile